drugset
Drugs / Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).
last change Nov 2008 re-read 3 minutes ago

Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).

also known as Bacille Calmette Guerin (BCG) · Tokyo 172 BCG

Vaccine

Developed for
tuberculosis
Investigated by
Aeras · Japan BCG Laboratory 4-2-6 Kohinata,Tokyo 112-0006, Japan. · University of Cape Town

Trials 1

today NCT00242047 · Ph 4
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00242047 Mar 2001 → Aug 2006 tuberculosis University of Cape Town Unknown Met primary

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG). ClinicalTrials.gov intervention name — accepted as the source's own label NCT00242047 ↗
Known as Bacille Calmette Guerin (BCG) “Japanese (Tokyo) 172 Bacille Calmette Guerin (BCG).” NCT00242047 ↗
Known as Tokyo 172 BCG “Infants were randomised by week of birth to receive Tokyo 172 BCG vaccine through the percutaneous route” PMID 19008268 ↗ Nov 2008
Modality Vaccine “Tokyo 172 BCG vaccine” PMID 19008268 ↗ Nov 2008
Route Other “percutaneous route of administration” NCT00242047 ↗